Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | HTR1B | P28222 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | HTR1D | P28221 | 1/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.48 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8909905 | 0.98 | TDP1 (0.62) | TDP1MAPK1KCNA3HPGDEPHX2 | |
| Methylamine SCHEMBL28044371 | 0.96 | TDP1 (0.66) | TDP1MAPK1KCNA3HPGDEPHX2 | |
| SCHEMBL7449489 | 0.89 | KCNA3 (0.62) | TDP1MAPK1KCNA3HPGDTAAR1 | |
| SCHEMBL27451022 | 0.89 | MAPK1 (0.56) | TDP1MAPK1KCNA3HPGDEPHX2 | |
| 1,4-Diisopentoxybenzene SCHEMBL2846102 | 0.88 | TDP1 (0.79) | TDP1MAPK1EPHX2ALDH1A1LMNA | |
| SCHEMBL11580701 | 0.87 | KCNA3 (0.67) | TDP1MAPK1KCNA3HPGDTAAR1 | |
| SCHEMBL9503356 | 0.86 | KCNA3 (0.58) | TDP1MAPK1KCNA3SIGMAR1TAAR1 | |
| SCHEMBL11068531 | 0.85 | KCNA3 (0.64) | TDP1MAPK1KCNA3HPGDTAAR1 | |
| SCHEMBL12746095 | 0.85 | KCNA3 (0.64) | TDP1MAPK1KCNA3HPGDTAAR1 | |
| SCHEMBL358609 | 0.85 | KCNA3 (0.64) | TDP1MAPK1KCNA3HPGDTAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119656881-B | Reverse osmosis membrane with coralloid structure and preparation method and application thereof | 苏州实验室 | 2025-05-23 | — | — | CN | claimed |
| CN-119656881-A | Reverse osmosis membrane with coralloid structure and preparation method and application thereof | 苏州实验室 | 2025-03-21 | — | — | CN | claimed |
| US-20190209441-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-07-11 | — | — | US | claimed |
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | WELLA OPERATIONS US, LLC | 2019-06-27 | — | — | US | claimed |
| US-20190175476-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | WELLA OPERATIONS US, LLC | 2019-06-13 | — | — | US | claimed |
| WO-2018053183-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORPORATION (US) | 2018-03-22 | — | — | WO | claimed |
| WO-2018053065-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-22 | — | — | WO | claimed |
| EP-3295925-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | Noxell Corporation (US) | 2018-03-21 | — | — | EP | claimed |
| WO-2018048933-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | claimed |
| WO-2018048924-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | claimed |
| US-20140227201-A1 | Antimicrobial Gel Formulations | NOVABAY PHARMACEUTICALS, INC. | 2014-08-14 | — | — | US | claimed |
| JP-2012500209-A | — | — | 2012-01-05 | — | — | JP | claimed |
| CN-102176818-A | Antimicrobial gel formulations | NOVABAY PHARMACEUTICALS INC | 2011-09-07 | — | — | CN | claimed |
| EP-2312939-A1 | ANTIMICROBIAL GEL FORMULATIONS | NovaBay Pharmaceuticals, Inc. (US) | 2011-04-27 | — | — | EP | claimed |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. | 2010-03-25 | — | — | US | claimed |
| WO-2010019723-A1 | ANTIMICROBIAL GEL FORMULATIONS | NOVABAY PHARMACEUTICALS, INC. (US) | 2010-02-18 | — | — | WO | claimed |
| US-5972864-A | BLEACHING BLOCK; MIXTURE OF BLEACH AND ORGANOLEPTIC COMPOUND | LONZA INC. (US) | 1999-10-26 | — | — | US | claimed |
| EP-0299561-B1 | Perfume and bleach compositions | UNILEVER NV (NL) | 1996-01-10 | — | — | EP | claimed |
| US-4582635-A | SUSTAINED RELEASE | TAKASAGO PERFUMERY CO., LTD. (JP) | 1986-04-15 | — | — | US | claimed |
| US-4296222-A | Manufacture of poly-α-olefins | BASF AKTIENGESELLSCHAFT (DE) | 1981-10-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190192408-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | MAL2, MSH6, OR51E2 | TDP1 3156/4885MAPK1 2461/4885KCNA3 1287/4885 |
| US-20140227201-A1 | Antimicrobial Gel Formulations | CUTA, TUBA3C, POLR1C | TDP1 1861/4885MAPK1 4567/4885KCNA3 2617/4885 |
| US-20100076089-A1 | ANTIMICROBIAL GEL FORMULATIONS | CUTA, TUBA3C, POLR1C | TDP1 1861/4885MAPK1 4567/4885KCNA3 2617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.